| Sandra Schlean Lerner, DO | |
|
29645 W 14 Mile Rd, Suite 110, Farmington Hills, MI 48334-1666 | |
| (248) 254-6000 | |
| (248) 254-6001 |
| Full Name | Sandra Schlean Lerner |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 22 Years |
| Location | 29645 W 14 Mile Rd, Farmington Hills, Michigan |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225018781 | NPI | - | NPPES |
| 4789086 | Medicaid | MI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 5101015209 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Beaumont Hospital Royal Oak | Royal oak, MI | Hospital |
| Entity Name | M & Y Care, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710527569 PECOS PAC ID: 6507044948 Enrollment ID: O20200121001542 |
News Archive
Genzyme Corporation today announced that it has completed the sale of its diagnostic products business to Sekisui Chemical Co., Ltd. for $265 million in cash.
Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited has signed an agreement with Tibotec Pharmaceuticals for a non-exclusive license to manufacture, market and distribute a generic version of the non-nucleoside reverse transcriptase inhibitor Rilpivirine Hydrochloride (TMC278), pending its regulatory approval for the treatment of treatment-naive HIV-1-infected adults.
Three well-known psychiatric researchers from Harvard Medical School may have violated federal and educational institution regulations by failing to properly disclose drug industry payments and other conflicts of interest, according to an investigation report published last week by Sen. Chuck Grassley (R-Iowa) in the Congressional Record, the Wall Street Journal reports (Armstrong, Wall Street Journal, 6/9).
Smisson-Cartledge Biomedical LLC, an innovator in life saving cardiovascular devices, announced today that its ThermaCor 1200 Rapid Thermal Infusion System has been used successfully in multiple clinical cases in the United States and in the Kingdom of Saudi Arabia.
Scientists have discovered a new phenomenon in which one bacterial cell can stop the growth of another on physical contact. The bacteria that stop growing may go into a dormant state, rather than dying. The findings have implications for management of chronic diseases, such as urinary tract infections.
› Verified 6 days ago
| Entity Name | Sandra S Lerner Do Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922707140 PECOS PAC ID: 9234503582 Enrollment ID: O20230328001476 |
News Archive
Genzyme Corporation today announced that it has completed the sale of its diagnostic products business to Sekisui Chemical Co., Ltd. for $265 million in cash.
Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited has signed an agreement with Tibotec Pharmaceuticals for a non-exclusive license to manufacture, market and distribute a generic version of the non-nucleoside reverse transcriptase inhibitor Rilpivirine Hydrochloride (TMC278), pending its regulatory approval for the treatment of treatment-naive HIV-1-infected adults.
Three well-known psychiatric researchers from Harvard Medical School may have violated federal and educational institution regulations by failing to properly disclose drug industry payments and other conflicts of interest, according to an investigation report published last week by Sen. Chuck Grassley (R-Iowa) in the Congressional Record, the Wall Street Journal reports (Armstrong, Wall Street Journal, 6/9).
Smisson-Cartledge Biomedical LLC, an innovator in life saving cardiovascular devices, announced today that its ThermaCor 1200 Rapid Thermal Infusion System has been used successfully in multiple clinical cases in the United States and in the Kingdom of Saudi Arabia.
Scientists have discovered a new phenomenon in which one bacterial cell can stop the growth of another on physical contact. The bacteria that stop growing may go into a dormant state, rather than dying. The findings have implications for management of chronic diseases, such as urinary tract infections.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sandra Schlean Lerner, DO 130 Town Center Dr Ste 203, Beaumont Medical Staff Affairs, Troy, MI 48084-1744 Ph: (248) 585-8218 | Sandra Schlean Lerner, DO 29645 W 14 Mile Rd, Suite 110, Farmington Hills, MI 48334-1666 Ph: (248) 254-6000 |
News Archive
Genzyme Corporation today announced that it has completed the sale of its diagnostic products business to Sekisui Chemical Co., Ltd. for $265 million in cash.
Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited has signed an agreement with Tibotec Pharmaceuticals for a non-exclusive license to manufacture, market and distribute a generic version of the non-nucleoside reverse transcriptase inhibitor Rilpivirine Hydrochloride (TMC278), pending its regulatory approval for the treatment of treatment-naive HIV-1-infected adults.
Three well-known psychiatric researchers from Harvard Medical School may have violated federal and educational institution regulations by failing to properly disclose drug industry payments and other conflicts of interest, according to an investigation report published last week by Sen. Chuck Grassley (R-Iowa) in the Congressional Record, the Wall Street Journal reports (Armstrong, Wall Street Journal, 6/9).
Smisson-Cartledge Biomedical LLC, an innovator in life saving cardiovascular devices, announced today that its ThermaCor 1200 Rapid Thermal Infusion System has been used successfully in multiple clinical cases in the United States and in the Kingdom of Saudi Arabia.
Scientists have discovered a new phenomenon in which one bacterial cell can stop the growth of another on physical contact. The bacteria that stop growing may go into a dormant state, rather than dying. The findings have implications for management of chronic diseases, such as urinary tract infections.
› Verified 6 days ago
Dr. Randall T Wurtz, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 23800 Orchard Lake Rd, Ste 100, Farmington Hills, MI 48336 Phone: 248-476-2420 Fax: 248-476-9709 | |
Lauren Noel Cole, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 28100 Grand River Ave Ste 313, Farmington Hills, MI 48336 Phone: 947-521-7150 | |
Saniya Jain, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 28100 Grand River Ave, Suite 313, Farmington Hills, MI 48336 Phone: 947-521-7150 | |
Dr. Joanne Louise Mckune, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 36253 Old Homestead Dr, Farmington Hills, MI 48335 Phone: 248-477-1433 | |
Matthew John Sebastian, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 28100 Grand River Ave Ste 313, Farmington Hills, MI 48336 Phone: 947-521-7150 Fax: 248-426-2473 | |
Mira Hamame, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 29645 W 14 Mile Rd Ste 110, Farmington Hills, MI 48334 Phone: 248-254-6000 Fax: 248-254-6001 | |
Marisa Burla, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 28100 Grand River Ave, Suite 313 South, Farmington Hills, MI 48336 Phone: 248-615-7150 Fax: 248-426-2473 |